6th Edition of Cardiology World Conference
September 15-17, 2025 | London, UK
Cerebral Blood Flow and Metabolism
Cerebral Blood Flow : CBF is explained as the blood volume that flows per unit mass per unit time in brain tissue and is typically indicates in units of ml blood. Direct methods for calculating CBF in human subjects include single-photon emission computed tomography (SPECT), positron emission tomography (PET), MRI with contrast agents, and arterial spin labeling (ASL) MRI.
CBF is controlled by four major mechanisms:
- Metabolic control (or 'metabolic autoregulation')
- Pressure autoregulation.
- Chemical control (by arterial pCO2 and pO2)
- Neural control.
Metabolism: Metabolism is used to express all chemical reactions included in continuing the living state of the cells and the organism. Metabolism can be efficiently divided into two categories: Catabolism and Anabolism. Catabolism refers to the breakdown of molecules to obtain energy and Anabolism refers to the synthesis of all compounds needed by the cells.
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Stephan Schueler
Newcastle upon Tyne Hospitals, United Kingdom
Sergey Suchkov
R&D Director of the National Center for Human Photosynthesis, Mexico
Agustin Joison
Cordoba Catholic University, Argentina
Zoya Khan
Lakeland Regional Health, United States
Michael Sabina
Lakeland Regional Health Medical Center, United StatesSubmit your abstract Today
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through biodesign-driven and inspired biotech, translational applications and cardiology-related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : TED2HOME - A low cost automatic external defibrillator for home/office
A Teddy Weiss, Hadassah University Hospital, Israel
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health – insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : The promising future of the unique translational tool to manage self-renewal of cardiac cells and to support regeneration in the post-infarction period
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico